Efficacy and safety of lesinurad for the treatment of hyperuricemia in gout
The aim of this review is to present current evidence about the efficacy and safety of lesinurad in combination with xanthine oxidase inhibitors (XOIs) in the treatment of hyperuricemia in patients with gout. Gout is the most common inflammatory form of arthritis. It is caused by an elevated concent...
Main Authors: | Fernando Pérez-Ruiz, Tim Jansen, Anne-Katrin Tausche, Mónica Juárez-Campo, Ravichandra Karra Gurunath, Pascal Richette |
---|---|
Format: | Article |
Language: | English |
Published: |
BioExcel Publishing Ltd
2019-05-01
|
Series: | Drugs in Context |
Subjects: | |
Online Access: | https://www.drugsincontext.com/efficacy-and-safety-of-lesinurad-for-the-treatment-of-hyperuricemia-in-gout |
Similar Items
-
Febuxostat as an effective drug of choice for urate-lowering therapy for gout (case report)
by: A. B. Bashkova, et al.
Published: (2022-08-01) -
UPDATED EULAR GUIDELINES FOR THE MANAGEMENT OF GOUT. COMMENTS ON CERTAIN ITEMS
by: M. S. Eliseev
Published: (2018-01-01) -
Uric acid, gout and cardiovascular diseases: prospects for the use of urat-lowering medications
by: M. S. Eliseev, et al.
Published: (2019-08-01) -
Comorbidity in gout and hyperuricemia: prevalence, causes, prospects of urate lowering therapy
by: M S Eliseev, et al.
Published: (2019-05-01) -
Modern paradigm of treatment of hyperuricemia and gout in comorbid patients with the development of cardio-vascular pathology
by: V. I. Mazurov, et al.
Published: (2020-12-01)